Levy Adam D.
Insider CIK 2061876 · ACRV Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2026-08-04 | 2026-08-06 | 1,142 | $1.57 | $1.8K | 66,008 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | S Sale | 2026-08-04 | 2026-08-06 | 1,142 | $1.57 | $1.8K | 66,008 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2026-05-18 | 2026-05-20 | 46,167 | — | $0 | 67,150 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2026-03-01 | 2026-03-03 | 132,925 | — | $0 | 132,925 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | P Buy | 2026-01-14 | 2026-01-16 | 8,832 | $1.70 | $15.0K | 20,983 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | F Tax w/h | 2025-08-01 | 2025-08-05 | 1,164 | $1.26 | $1.5K | 12,151 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2025-04-01 | 2025-04-03 | 35,209 | — | $0 | 35,209 | SEC↗ |